New England Journal of Medicine/the New England Journal of Medicine, 384(11), 9891002
Recent studies have demonstrated that stimulants, along with the non-stimulants atomoxetine and extended-release guanfacine, are continuously effective for more than 2-year treatment periods with few and tolerable adverse effects
GLP1 receptor agonists do not seem to suppress baseline accumbal dopamine, as opposed to the modulation of stimulated levels, and modulation may differ between NAc shell and core regions (Egecioglu, Engel, & Jerlhag, 2013a
He said the company is confident in being able to scale up manufacturing of the treatment
Traditional diets often fail because weight loss isnt just about willpower or doing more cardio its about getting the right support and tools